
Sign up to save your podcasts
Or


Both remdesivir and dexamethasone have been promoted as effective treatments for COVID-19. JAMA Deputy Editor Greg Curfman, MD, and Professor Rachel Sachs, JD, from the Washington University School of Law discuss the science and health policy aspects of these COVID-19 treatments.
Related Article(s):
Missed Opportunities on Emergency Remdesivir Use
By JAMA Network4.3
106106 ratings
Both remdesivir and dexamethasone have been promoted as effective treatments for COVID-19. JAMA Deputy Editor Greg Curfman, MD, and Professor Rachel Sachs, JD, from the Washington University School of Law discuss the science and health policy aspects of these COVID-19 treatments.
Related Article(s):
Missed Opportunities on Emergency Remdesivir Use

498 Listeners

162 Listeners

8,857 Listeners

111,848 Listeners

38 Listeners

21 Listeners

12 Listeners

11 Listeners

9 Listeners

16 Listeners

19 Listeners

5 Listeners

7 Listeners

30 Listeners

9 Listeners

94 Listeners

14 Listeners

5 Listeners

5 Listeners

367 Listeners

5,802 Listeners

18 Listeners

3 Listeners